LUXTURNA
NDC 71394-415, voretigene neparvovec-rzyl, kit, from Spark Therapeutics, Inc..
- Product NDC
- 71394-415
- Status
- Listed
- Labeler
- Spark Therapeutics, Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125610
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71394-415 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71394-415-01 | 71394041501 | 1 KIT in 1 CARTON (71394-415-01) * 1 INJECTION, SUSPENSION in 1 VIAL, PLASTIC (71394-065-01) * 1 INJECTION, SOLUTION in 1 VIAL, PLASTIC (71394-716-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/08313a24-e7ce-457a-bb3f-161bc45517ee
Use it
Look up 71394-415 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71394-415 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71394-415. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.